Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

Clinical trial NCT04838301 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04838301
Sponsor: University of Arizona
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Dementia Late Onset Alzheimer Disease Neurodegenerative Diseases

Start date: 2023-08-15
Primary completion: 2026-11-18
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.